![Xue Bin Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Xue Bin Liu is the founder of MingMed Biotechnology Co., Ltd.
He held the title of Executive Director in 2022, but is no longer active in that role.
MingMed Biotechnology Co., Ltd.
was founded in 2019.
Ehemalige bekannte Positionen von Xue Bin Liu
Unternehmen | Position | Ende |
---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Gründer | 27.07.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |